Effects of Oxytocin and Vasopressin on Moral Decision Making
NCT ID: NCT04890470
Last Updated: 2023-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
180 participants
INTERVENTIONAL
2021-03-02
2022-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Oxytocin and Vasopressin on Delta-beta Cross-frequency Coupling
NCT06605300
Oxytocin's Effect on the Advantageous- and Disadvantageous-inequity
NCT06405737
The Neural Basis of Oxytocin's Effects on Empathy
NCT03084029
The Modulatory Effect of Oxytocin on Interoception
NCT03074409
Effects of Oxytocin on Reinforcement Learning and Interoception
NCT05245708
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oxytocin group
subjects with oxytocin treatment
Oxytocin
intranasal administration of oxytocin (24 IU)
vasopressin group
subjects with vasopressin treatment
Vasopressin
intranasal administration of vasopressin (20 IU)
placebo group
subjects with placebo treatment
Placebo
intranasal administration of placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxytocin
intranasal administration of oxytocin (24 IU)
Vasopressin
intranasal administration of vasopressin (20 IU)
Placebo
intranasal administration of placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Electronic Science and Technology of China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Keith Kendrick
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keith M. Kendrick
Role: PRINCIPAL_INVESTIGATOR
University of Electronic Science and Technology of China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xiaoxiao Zheng
Sichuan, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UESTC-neuSCAN-78
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.